
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇦CA · Medicine#1225K to 30K
- 🇧🇷BR · Medicine#1551K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
3K to 20K🎙 Weekly cadence·81 episodes·Last published 3d ago - Monthly Reach
Unique listeners across all episodes (30 days)
6K to 40K🇨🇦75%🇧🇷25% - Active Followers
Loyal subscribers who consistently listen
1.8K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 1 epsHosts
Not detected.
Recent guests
Recent episodes
APP Pulse Episode 1: HRT After Gynecologic Cancer: Myth vs. Reality
Jun 25, 2026
35m 52s
Highlights from ESMO 2025
Mar 4, 2026
26m 21s
Updates to the CY26 Medicare Physician Fee Schedule
Feb 19, 2026
20m 47s
Part 3: SGO Keeping up with the Chemos: Treatment of Interstitial Lung Disease (ILD)
Oct 27, 2025
20m 21s
Part 2: SGO Keeping up with the Chemos: Prevention and Monitoring of Interstitial Lung Disease (ILD)
Oct 27, 2025
19m 35s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/25/26 | ![]() APP Pulse Episode 1: HRT After Gynecologic Cancer: Myth vs. Reality | Hormone replacement in patients with gynecological cancer has always been a controversial topic. The guests on this episode help to debunk the myths and give guidance on how to have these important conversations and when to offer HRT to our patients. Hosts: Nicole Dreibelbis, CRNP, WHNP-BC, Sarah Irish, DNP, APRN, FNP-BC Guests: Jessie Dorne, PA, Rachel Frankenthal, PA-C, MPH, MSCP Additional Resources: https://heatherhirschacademy.com/course/managing-hormone-therapy-for-gynecologic-cancer-... | 35m 52s | ||||||
| 3/4/26 | ![]() Highlights from ESMO 2025✨ | oncologyclinical trials+3 | Lisa Rauh-Benoit, MD, MPHMichelle Boisen, MD | DUO-ORina-S/RAINFOL-1+2 | Berlin, Germany | ESMO 2025oncology trials+3 | — | 26m 21s | |
| 2/19/26 | ![]() Updates to the CY26 Medicare Physician Fee Schedule | Stephen Bush, MD, Vice Chair of the SGO Coding and Reimbursement Committee and Kay Moyer, Director of Regulatory Affairs, CRD Associates, discuss changes in Medicare Part B policies and payments and how those impact gynecologic oncologists in 2026. Resources: SGO Comments to the Medicare Physician Fee Schedule: SGO-MPFS-PR-2026-_-FINAL.pdfAn Update on the CY2026 Medicare Physician Fee Schedule Final Rule | Society of Gynecologic Oncology | 20m 47s | ||||||
| 10/27/25 | ![]() Part 3: SGO Keeping up with the Chemos: Treatment of Interstitial Lung Disease (ILD) | Listen to part 3 of the three-part series "Keeping up with the Chemos" focusing on the treatment of Interstitial Lung Disease (ILD). Moderator: Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBA Paolo Tarantino, MD, PhD Ira Winer MD, PhD, FACOG Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). | 20m 21s | ||||||
| 10/27/25 | ![]() Part 2: SGO Keeping up with the Chemos: Prevention and Monitoring of Interstitial Lung Disease (ILD) | Listen to part 2 of the three-part series "Keeping up with the Chemos" focusing on prevention and monitoring of Interstitial Lung Disease (ILD). Moderator: Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBA Paolo Tarantino, MD, PhD Ira Winer MD, PhD, FACOG Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). | 19m 35s | ||||||
| 10/27/25 | ![]() Part 1: SGO Keeping up with the Chemos: Therapies Associated with Interstitial Lung Disease (ILD) | Listen to part 1 of the three-part series "Keeping up with the Chemos" on the therapies associated with Interstitial Lung Disease (ILD). Moderator: Jennifer MacDonald, PharmD, BCOP Speakers: Charles Powell, MD, MBA Paolo Tarantino, MD, PhD Ira Winer MD, PhD, FACOG Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). | 29m 41s | ||||||
| 10/20/25 | ![]() Cracking the Code, Understanding Time-based Coding | Kaitlin Nicholson, MD and Katherine Tucker, MD, from the SGO Coding and Reimbursement Committee share their expertise in time-based coding to support your billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee. | 18m 18s | ||||||
| 9/5/25 | ![]() Cracking the Code, Understanding Risk, Morbidity, and Mortality | Carolyn Haunschild , MD and Sameer Sharma, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding and discuss how risk of complications, morbidity and mortality of patient management factor into billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Subcommittee. | 28m 18s | ||||||
| 6/10/25 | ![]() Cracking the Code, Understanding Medical Complexity in Medical Decision Making | Kimberly Levinson, MD, MPH, and Kaitlin Nicholson, MD, from the SGO Coding and Reimbursement Committee share their expertise in E/M coding to demystify the use of medical complexity data to support your billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee. | 19m 39s | ||||||
| 5/2/25 | ![]() Experiences with Nurse Navigators in Gyn Onc: Part 2 | As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. Tune in to part two, as the discussion continues between Dr. Emily Wu and the panel of nurse navigators on the multi-faceted function of navigators and how to incorporate nurse navigation into a clinical practice. Moderator: Emily Wu, MD Overlake Medical Center Speakers: Julie Rodriguez, BSN, RN, OCN University of ... | 19m 52s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/2/25 | ![]() Experiences with Nurse Navigators in Gyn Onc: Part 1 | As we all know, cancer care can feel incredibly complicated and overwhelming to patients – many of whom may face logistical, financial, and social barriers. Given the complexities of our healthcare systems, this episode provides insight on ways a clinical practice can better support their patients. Tune in to this two-part episode as the Dr. Emily Wu interviews a panel of nurse navigators on their unique experiences within the role, the multi-faceted function of navigators, and how to incorp... | 22m 42s | ||||||
| 4/10/25 | ![]() Cracking the Code, Understanding Number and Acuity of Diagnosis in Medical Decision Making | Allison Barrie, MD, and Stephen Bush, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding to unlock the secrets of using the number and complexity of diagnoses to support your billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Chair of the SGO Coding and Reimbursement Subcommittee. | 24m 28s | ||||||
| 1/7/25 | ![]() SGO Ways to Wellness: An Open Letter to My Former Self | During the SGO 2024 Winter Meeting, Wellness Committee volunteers asked SGO members what advice they would give to their younger selves. Members at various stages of their medical career offered words of wisdom for trainees and new attendings in gynecologic oncology. Tune in to hear about challenges that members experienced, their journey to growth and self-care, and how they learned to find support through community and mentorship. Moderator: Hui (Amy) Chen, MD Speakers: Katherine Fuh,... | 12m 17s | ||||||
| 10/28/24 | ![]() SGO Oncofertility Part 2: Risks of Premature Ovarian Failure | Maximizing reproductive fertility options is just as important as beating cancer, primarily bridging the gap for patient education and fertility resources. Join Dr. Jennifer MacDonald as she interviews Drs. Scott Richard and Rachel Danis, addressing premature ovarian failure, ovarian preservation, and how chemo agents, radiation, and surgery can affect the patient’s natural fertility options. 2024-2025 SGO Chemotherapy and Immunotherapy Subcommittee Lead and Moderator: Jennifer MacDona... | 14m 24s | ||||||
| 10/28/24 | ![]() SGO Oncofertility Part 1: Giving Patients Ownership of their Future Fertility Options | Listen to Dr. Jennifer MacDonald interview Drs. Scott Richard and Rachel Danis, discussing the importance of fertility preservation for cancer patients, partnering with a reproductive endocrinology and infertility clinic (REI) to expand fertility options for future family building, and patients utilizing grant/nonprofit funding resources to financially assist with fertility treatment options. 2024-2025 SGO Chemotherapy Immunotherapy Subcommittee Lead and Moderator: Jennifer MacDonald, PharmD... | 26m 40s | ||||||
| 10/8/24 | ![]() Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (CDK 4/6 inhibitors) | This is the last of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the challenges with patient monitoring while on CDK 4/6 inhibitors. When to dose adjust and hold or even discontinue CDK 4/6 inhibitors. Once again, the podcast ends with take home points for patient monitoring, medication management, and side effects while on CDK 4/6 inhibitors. 2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Mod... | 16m 40s | ||||||
| 10/8/24 | ![]() Part 2: Keeping up with the Chemos Series: Administration of CDK 4/6 inhibitors | This is the second of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of CDK 4/6 inhibitors. Focusing on dosing, supportive care, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator: Jennifer Mac... | 16m 55s | ||||||
| 10/8/24 | ![]() Part 1: Keeping up with the Chemos Series: Preparing to Give CDK 4/6 inhibitors | This is the first of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. After going over some general information on CDK 4/6 inhibitors including when to use the drug, toxicity, response rates, repeat biopsy, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving CDK 4/6 inhibitors. The session wraps up with some key take home points on CDK 4/6 inhibitors. 2024-2025 SGO Chemotherapy and Immunolo... | 10m 10s | ||||||
| 10/4/24 | ![]() Encouraging Self-Advocacy in the Cervical Cancer Journey | Let’s do this -- This podcast features patient advocates who share their experiences and offer valuable insights from their journeys as cervical cancer patients and survivors. It is hosted by the Health Equity Subcommittee, a division of the SGO Diversity, Inclusion, and Health Equity (DIHE) Committee. Moderators: Lindsay Kuroki, MD, MSCI, Washington University Physicians, DIHE Health Equity subcommittee ChairNancy Zhou, MD, Rutgers Health - NJMS, DIHE Health Equity subcommittee Member ... | 26m 32s | ||||||
| 6/18/24 | ![]() Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Trastuzumab Deruxtecan ENHERTU®) | This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®. 2023-2024 SGO Chemotherapy and Targeted... | 11m 52s | ||||||
| 6/18/24 | ![]() Part 2: Keeping up with the Chemos Series: Administration of Trastuzumab Deruxtecan ENHERTU® | This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®. Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2023-2024 SGO... | 14m 08s | ||||||
| 6/18/24 | ![]() Part 1: Keeping up with the Chemos Series: Preparing to Give Trastuzumab Deruxtecan ENHERTU® | This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving Trastuzumab Deruxtecan ENHERTU®. The session wraps up with some key take home ... | 21m 45s | ||||||
| 5/3/24 | ![]() ERAS Guidelines: Same Day Discharge (SDD) | In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS). Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity. Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and m... | 13m 27s | ||||||
| 3/11/24 | ![]() Immunotherapy Part 3: Common Controversies and Remaining Questions | This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy C... | 17m 57s | ||||||
| 3/11/24 | ![]() Immunotherapy Part 2: Common Controversies | This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticosteroids, re-challenging after toxicity, use of ICIs in patients with auto-immune conditions, and drug interactions. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin... | 22m 47s | ||||||
Showing 25 of 82
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.
